Trials / Unknown
UnknownNCT03022669
Mobile Health Strategies for Veterans
Mobile Health Strategies for Veterans With Coronary Heart Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 225 (estimated)
- Sponsor
- San Francisco Veterans Affairs Medical Center · Federal
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether text messages/messaging (TM) or a mobile application (app), compared with an educational website-control provided to all Veterans, can improve adherence to antiplatelet therapy among patients following acute coronary syndrome or percutaneous coronary intervention (ACS/PCI).
Detailed description
Adherence to antiplatelet medications is critical to prevent life threatening complications (i.e., stent thrombosis); yet rates of non-adherence range from 21-57% by 12 months. Mobile technology through TM or mobile apps is a practical and inexpensive strategy to promote behavior change and enhance medication adherence. The three specific aims of this proposal are to: 1) determine preferences for content and frequency of TM to promote medication adherence through focus groups; 2) determine the most patient-centered app to promote adherence through a content analysis of all commercially available apps for medication adherence and focus groups centered on usability; and 3) compare adherence to antiplatelet medications in 225 Veterans post ACS/PCI through a randomized controlled trial. Participants will be randomized to either TM, mobile app, or website-control group. The focus groups will be stratified by low/high mobile phone use and sex.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Text Message | Annie (VA text messaging program) or mobile Health manager (private text messaging program for non-VA female participants recruited at non-VA facility) |
| BEHAVIORAL | Mobile Application | |
| OTHER | Website | American Heart Association patient education website |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
- First posted
- 2017-01-16
- Last updated
- 2021-09-29
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03022669. Inclusion in this directory is not an endorsement.